this looks alittle crazy to me1. above monthly open
2. above weekly open
3. above prior days high and low
Gap above bullish candle...expect to see retracement. Prior similar gap ran up
BNTX/N trade ideas
BNTxDescending trinagle. Support 118. Reistance 150. Big area to chop. Upside target if break 150 and close above we would target 209. If we break and hold below 118 as reistance then we would target 47/50$. This could be a nice pickup closer to the 118 zone of support. Buyers are holding that level as of now. Buying any dip unless 118 is broken and starting to close below
BNTX - Biotechnology Bear BeginsBNTX looks to be completing a primary B wave retracement to begin the bio bear market.
Target $167.
Not advice.
#BNTX #Biontech long ideaBNTX Price finds support at monthly pivot S1 line and daily inside bar has been formed.
Close above 150.3$ triggers idea with profit target 187$ and stop 145$.
Risk Reward ratio 7.0
BNTX is facing an armed angry bear !Angry bear has mad a weapon integrating three powerful and heavy elements and waiting for the stock to hammer it down !
Long term down trend line , 200 days moving average and lost golden ratio Retracement level are the elements of the bear's weapon.
Can BNTX make a heroic attack and defeat the angry bear? Not without a powerful comparable weapon I think. It needs a brilliant earning report or next wave of Covid or more positive sentiment in all market to survive facing such a frightening enemy.
Anyways, I am excited to watch this up coming battle ! Who wins? Lest follow and watch closely.
BNTX will pop-up on next earnings dayBNTX will pop-up on next earnings day.
Technicals suggest the stock has been building a bottom the last couple of months. Now is well above the 50 day EMA and it is begining to challenge the 200 day EMA.
The P/E ratio and Forward P/E ratio are in the low single digits.
I expanded my position when BNTX crossed above the 50 day EMA.
$BNTX Buy Above $ 170 or Sell Below 159Buy Above $ 170
TGT- 180
TGT-2- 186
SL 159
Sell Below 159
TGT- 153
TGT-2 149
SL 165
BioNTech showing a solid entryBNTX is finally concluding a year long descending triangle pattern. I see a low risk entry at $150 and will be buying. Stop loss set at $138.49, risking about 8.5%. If we see a large move upward, I could see the stock retesting both its 200 day moving average (likely at $183) and its next major resistance after that at $295. A potential of nearly 100% profit (not to say its a sure bet or smart to dump huge amounts into the trade without the stop loss...). Fundamentally, the company has a P/E of 3, no debt, and a huge free cash flow to fund its mrna platforms for a lot of other diseases partnering with some of the largest pharma companies in the world. Yet another variant of covid, upward pressure from the 50and100 day MAs, large portions of the world unvaccinated, and president biden contracting the virus could be potential catalysts for a move. If you're looking for a bio tech exposure this is a stock that seems to be set up well. Good luck to all.
$BNTX #breakout - the vaccine against portfolio loses?:)$BNTX Breakout in 1h Chart
1. Positive Super Trend in 4h Chart & Consolidation > 8 days
2. Several touching points with vwap
3. Price above 10, 20 & 50 EMA
4. Target 205$
5. Stop-Loss 164$
6. Risk Reward Ratio 11.3
$BNTX with a Bullish outlook following its earnings #Stocks The PEAD projected a Bullish outlook for $BNTX after a Positive Under reaction following its earnings release placing the stock in drift A.
BionTech - Financial Health ExcellentThe Statistics say between $182-$253 (1 year)
This Looks like it can Happen in 1 Year.
That will depend on their Progress.
Let's see what will happen in 2023,
but it looks ok to hold for the next 5 Years or more
BioNTech aims to develop the first mRNA-based vaccine for Malaria
prevention with the initiation of a clinical trial by end of 2022
BioNTech is evaluating sustainable mRNA vaccine production capacities in Africa;
the Company’s efforts are supported by the joint convening powers of the World Health Organization (WHO)
and the Africa Centers for Disease Control and Prevention (Africa CDC)
BioNTech’s Malaria project is part of the ‘eradicate malaria’ initiative,
led by the kENUP Foundation, to accelerate the eradication of Malaria
Disclaimer:
Just my Idea! Find your Trading Ideas and learn and study more!
BNTX continues to generate strong revenues Entering here for a possible inv h&s continuation targeting 240. (1.618 fib level).
Stop loss @120. Should be a good spot to take profits and leave half running.
Free Fallinnnnn $bntx has NO volume support until green box 24% lower... #bntx
——————————————————————————————
Top 10 trading tips:
1. DO NOT FOMO into a trade. Let it come to you. Don’t force it.
2. Find a strategy that works for you and be consistent. Operate like a machine and less like the wind.
3. Let your winners run and cut your losers short.
4. You will not win every trade, but if you are disciplined with great RM you don't need to be right all the time to win!
5. Before you enter a trade, know your target AND your exit strategy.
6. When you are up, you can use a trailing stop or trim off some profit at a logical resistance point with a stop loss at breakeven.
7. Set your trade parameters up front so you keep your self accountable and remove emotions from the equation. (stop loss, take profit levels, etc)
8. Don't fight the trend. The trend is your friend.
9. Don’t enter a trade based on one indicator.
10. Horizontals > Diagonals
Please note:
- This is not financial advice.
- I do not take every trade I post.
- Never trade off of someone else's chart until you DYOR!
BioNTech earnings 3/30 pre-marketBioNTech Q4 December 21' earnings are on 3/30 pre-market 6:45am. BioNTech Se ADR (BNTX) reported Q3 September 2021 earnings of $14.56 per share on revenue of $7.2 billion. The consensus earnings estimate was $11.79 per share on revenue of $5.8 billion. Revenue grew 9,003.0% on a year-over-year basis. I'm long now because a P/E = 3.7 for a leading MRNA biotechnology company heading into earnings is a rare opportunity. Plus, I waited until today from the technical entry I planned on Friday. Here's levels on the 1-day chart:
Q4 December 21' Consensus:
P/E = 3.7
EPS = $8.45
Revenue = $4.48B
52 week high = $464
52 week low = $93
SMA200 = $217
SMA100 =$206
breakout = $179
R3 = $169
R2 = $159
R1 = $150
pivot = $140
S1 = $130
S2 = $120
S3 = $111
breakdown = $101
Do your own due diligence, your risk is 100% your responsibility. This is for educational and entertainment purposes only. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Good luck and happy trading friends...
*3x lucky 7s of trading*
7pt Trading compass:
Price action, entry/exit
Volume average/direction
Trend, patterns, momentum
Newsworthy current events
Revenue
Earnings
Balance sheet
7 Common mistakes:
+5% portfolio trades, capital risk management
Beware of analyst's motives
Emotions & Opinions
FOMO : bad timing, the market is ruthless, be shrewd
Lack of planning & discipline
Forgetting restraint
Obdurate repetitive errors, no adaptation
7 Important tools:
Trading View app!, Brokerage UI
Accurate indicators & settings
Wide screen monitor/s
Trading log (pencil & graph paper)
Big, organized desk
Reading books, playing chess
Sorted watch-list
Checkout my indicators:
Fibonacci VIP - volume
Fibonacci MA7 - price
pi RSI - trend momentum
TTC - trend channel
AlertiT - notification
tickerTracker - MFI Oscillator
www.tradingview.com
BNTX HIGH RISK TO REWARD SETUP YOU CAN'T MISSNews - Better than expected Q4 EPS and sales results, the company expects to authorize a shares repurchase program up to 1.5B over the next two years.
Levels -$195 is the next major resistance level.
$138 is the next major support level.
The stock is gapping up to $183 (pre-market).
The idea is to go long at the open when it will try to test the $183 support level and fail, then go long above the 5M bull flag pattern if it will happen.
BNTX Earnings BreakBNTX has broken out nicely upon earnings
it also aligns nicely with the pattern price is portraying which is an ascending scallop, commonly considered a bullish pattern
BNTXUnderrated company in my opinion with perspective pipeline. Now it has 2/3 ichi confirmation + bullish rsi + incoming earnings, shall be more clear tomorrow
BNTX LONG SETUPWe just finished Elliot wave 1-5 and ABC pattern, already bounced off of a strong demand zone and 71.8% fib zone we can enter right now but our R/R ratio is 1.7 since we missed first bounce, what we are looking for is a retrace to our entry point ant 71.8% fib zone and enter there. Also market made a gap at 182 zone which has to be filled. Also a gap at 325 zone, which also needs to be filled.
AROON: On a daily chart AROON already shows bullish momentum (Orange line above blue one)
Bollinger band: we already bounced off of a bottom Bollinger band which indicates bullish direction movement.
Entry:119 (We can enter right now but for better R/R I would suggest to wait for a retest at the entry zone, though it might not do that and we might miss a trade)
Invalidation: 79 ( Just below Demand zone )
Target 1: 292 (50% FIB ZONE)
Target 2: 325 (Second gap zone)
Ratio if we wait for retest: 4.38
Ratio if we enter right now: 1.75
BNTX still could be profitable!Enter after breaking the trendline.
Even if the end of the epidemic has a big impact on the price, it is still possible enter a long position and be a winner!
Long Opportunity for BNTXBetween 150 to 155 seems best places to enter long position,
ENTRY: 150
SL: 140
TP1: 236
TP2: 288
TP3: 310
BIONTECH next long setupBIONTECH came to the next level of interest.
Alreday filled.
Pt´s shown in the chart
